K. Gaston

发表

Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer

D. Ornstein, K. Gaston, 2002, Expert opinion on pharmacotherapy.

Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer.

Desok Kim, J. Mohler, K. Gaston, 2003, The Journal of urology.

Racial differences in prostate androgen levels in men with clinically localized prostate cancer.

M. Schell, J. Mohler, D. Moore, 2004, The Journal of urology.

Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection.

C. Dinney, John W. Davis, M. Munsell, 2011, The Journal of urology.

Hand-assisted laparoscopic nephrectomy: prospective evaluation of the learning curve.

D. Moore, R. Pruthi, K. Gaston, 2004, The Journal of urology.

Racial differences in prostate cancer.

R. Pruthi, K. Gaston, 2006, North Carolina medical journal.

Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System

Jason Zhu, P. Clark, J. Matulay, 2021, Urology practice.

Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients

Jason Zhu, C. Brouwer, P. Clark, 2021, Translational andrology and urology.

A novel method for the analysis of the androgen receptor

J. Mohler, C. Gregory, K. Gaston, 2002, Current urology reports.

The Use of Erythropoietin in Patients Undergoing Radical Prostatectomy: Effects on Hematocrit, Transfusion Rates and Quality of Life

D. Moore, R. Pruthi, E. Kouba, 2006, Urologia Internationalis.

Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?

K. Gaston, D. Raghavan, E. Burgess, 2014, The oncologist.

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.

E. Wallen, R. Pruthi, K. Gaston, 2004, Urology.

Robot-Assisted Pelvic Lymphadenectomy

John W. Davis, K. Gaston, 2014 .

Safety of decreasing ureteral stent duration following radical cystectomy

P. Clark, K. Gaston, C. Hensel, 2020, World Journal of Urology.

Plasma cell (Zoon's) balanitis with concomitant HIV infection.

W. Funkhouser, K. Gaston, J. Lavelle, 2005, Urology.

Proteomic assays for the detection of urothelial cancer.

H. Grossman, K. Gaston, H. B. Grossman, 2010, Methods in molecular biology.

Nephron-Sparing Radical Excision of a Giant Perirenal Liposarcoma Involving a Solitary Kidney

K. Gaston, C. Teigland, R. White, 2007, The American surgeon.

Value of urinary cytology in the diagnosis and management of urinary tract malignancies.

R. Pruthi, K. Gaston, 2004, Urology.

Surgeon-Administered Transversus Abdominis Plane (TAP) Block is Associated with Decreased Opioid Usage and Length of Stay following Radical Cystectomy

P. Clark, K. Gaston, S. Riggs, 2021, Urology.

Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.

R. Pruthi, K. Gaston, E. Derksen, 2003, The Journal of urology.

Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer.

K. Gaston, D. Raghavan, E. Burgess, 2012, Seminars in oncology.

Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer.

K. Gaston, T. Kruser, M. Haake, 2016, Urologic oncology.

Association between lymph node density and disease specific survival in patients with penile cancer.

P. Tamboli, M. Munsell, P. Spiess, 2009, The Journal of urology.

Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis

P. Clark, K. Gaston, James T. Kearns, 2020, Rare tumors.

Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer

Jason Zhu, P. Clark, J. Matulay, 2022, Urology.

Urinary markers in screening patients with hematuria

K. Gaston, E. Chiong, H. B. Grossman, 2008, World Journal of Urology.

Decreasing ureteral stent duration following radical cystectomy decreases readmissions and urinary infectious complications.

P. Clark, K. Gaston, C. Hensel, 2019, Journal of Clinical Oncology.

Renal Mass Biopsy Mandate Is Associated With Change in Treatment Decisions

P. Clark, K. Gaston, S. Riggs, 2023, Journal of Urology.

IMPLEMENTATION OF A DEDICATED ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM FOR RADICAL CYSTECTOMY PATIENTS IS ASSOCIATED WITH DECREASED POSTOPERATIVE INPATIENT OPIOID USAGE AND PAIN SCORES.

P. Clark, K. Gaston, S. Riggs, 2020, Urology.

Clinical Utility of Postneoadjuvant Chemotherapy Computerized Tomography for Muscle Invasive Urothelial Bladder Cancer.

P. Clark, K. Gaston, James T. Kearns, 2020, Urology practice.

Mutational analysis of the androgen receptor using laser capture microdissection and direct sequencing.

J. Mohler, G. Flake, K. Gaston, 2003, Methods in molecular biology.

RCOM RADIOLOGICAL CASE OF THE MONTH

K. Gaston, J. Lavelle, D. Warshauer, 2005, Applied Radiology.

Persistent opioid and benzodiazepine use after radical cystectomy in enhanced recovery after surgery (ERAS) patients.

K. Gaston, Ziqing Yu, M. Wally, 2023, Urologic oncology.